SCHEMBL13699845

SCHEMBL13699845

NC(=O)c1oc2cc(F)c(F)cc2c1NC(=O)C1CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.57
TSHR P16473 6/20 0.57
ALDH1A1 P00352 5/20 0.57
HTT P42858 3/20 0.57
RXFP1 Q9HBX9 1/20 0.50
POLB P06746 2/20 0.47
MEN1 O00255 7/20 0.45
KMT2A Q03164 7/20 0.45
MAPT P10636 7/20 0.43
HSD17B10 Q99714 6/20 0.43
LMNA P02545 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
TP53 P04637 1/20 0.41
AHR P35869 1/20 0.41
MAPK10 P53779 1/20 0.41
RAB9A P51151 2/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
DHODH Q02127 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699847 0.90 KDM4E (0.53) KDM4ETSHRALDH1A1HTTRXFP1
SCHEMBL13699843 0.85 TSHR (0.61) KDM4ETSHRALDH1A1HTTRXFP1
SCHEMBL4255835 0.85 KDM4E (0.61) KDM4ETSHRALDH1A1HTTRXFP1
SCHEMBL13699856 0.80 TSHR (0.69) KDM4ETSHRALDH1A1HTTRXFP1
SCHEMBL13699848 0.80 TSHR (0.65) KDM4ETSHRALDH1A1HTTRXFP1
SCHEMBL4252530 0.80 KDM4E (0.69) KDM4ETSHRALDH1A1HTTRXFP1
SCHEMBL13699846 0.80 KDM4E (0.61) KDM4ETSHRALDH1A1HTTRXFP1
SCHEMBL4254059 0.80 KDM4E (0.61) KDM4ETSHRALDH1A1HTTRXFP1
SCHEMBL4254511 0.80 TSHR (0.49) KDM4ETSHRALDH1A1HTTRXFP1
SCHEMBL13699850 0.79 TSHR (0.71) KDM4ETSHRALDH1A1HTTRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885TSHR 231/4885ALDH1A1 559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.